# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3091126 | B | Competitive inhibition of human recombinant DPP4 using AP-pNA as substrate preincubated for 30 mins followed by substrate addition measured after 30 mins by spectrophotometric analysis | Homo sapiens | 5 | ALA3085773 | single protein format | Scientific Literature | |
2. | ALA3091133 | A | Stability of the compound assessed as half life of recombinant human APP2-mediated compound degradation at 0.1 mM by reverse-phase HPLC/MS analysis | Homo sapiens | 3 | ALA3085773 | single protein format | Scientific Literature | |
3. | ALA3091135 | A | Stability of the compound assessed as recombinant human FAPalpha-mediated compound degradation measuring intact level at 0.1 mM after 48 hrs by reverse-phase HPLC/MS analysis | Homo sapiens | 2 | ALA3085773 | single protein format | Scientific Literature | |
4. | ALA3091136 | A | Stability of the compound assessed as half life of recombinant human FAPalpha-mediated compound degradation at 0.1 mM by reverse-phase HPLC/MS analysis | Homo sapiens | 3 | ALA3085773 | single protein format | Scientific Literature | |
5. | ALA3091137 | B | Agonist activity at Y2 receptor (unknown origin) by beta-arrestin recruitment assay | Homo sapiens | 3 | ALA3085773 | single protein format | Scientific Literature | |
6. | ALA3091138 | B | Agonist activity at Y1 receptor (unknown origin) by beta-arrestin recruitment assay | Homo sapiens | 3 | ALA3085773 | single protein format | Scientific Literature | |
7. | ALA3090288 | A | Stability of the compound assessed as recombinant human DPP4-mediated compound degradation at 0.1 mM measured after 24 hrs by reverse-phase HPLC/MS analysis | Homo sapiens | 8 | ALA3085773 | single protein format | Scientific Literature |